• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Alkermes plc (ALKS)

    -NasdaqGS
    70.25 Down 0.98(1.38%) 4:00PM EST
    |After Hours : 70.26 Up 0.01 (0.01%) 4:38PM EST
    Add to Portfolio
    Prev Close:71.23
    Open:71.68
    Bid:68.00 x 100
    Ask:N/A
    1y Target Est:71.90
    Beta:1.36
    Next Earnings Date:N/A
    Day's Range:69.81 - 72.10
    52wk Range:38.49 - 74.96
    Volume:6,215,947
    Avg Vol (3m):1,302,910
    Market Cap:10.40B
    P/E (ttm):N/A
    EPS (ttm):-0.21
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALKS

    Comparison

    Symbol% ChgMkt Cap
    ALKSDown 1.38%10.40B
    ABTDown 0.50%71.33B
    LLYUp 0.20%74.42B
    GSKDown 0.88%114.07B

    Key Statistics

    Forward P/E (1 yr):351.25
    P/S (ttm):17.04
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.26
    Quarterly EPS Est (Mar-15) :-0.03
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):-38.59

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alkermes Public Limited Company, an integrated biopharmaceutical company, develops medicines that enhance patient outcomes. The company offers RISPERDAL CONSTA for schizophrenia and bipolar I disorder; INVEGA SUSTENNA to treat schizophrenia; AMPYR... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback